TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: ASCO 2018 GU Highlights

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: ASCO 2018 GU Highlights

By Beacon Medical Interchange FEATURING Daniel Goldstein

100 views

November 2, 2018

Dr. Dan Goldstein reviews results of a trial of chemo regimen TIP (paclitaxel, ifosfamide, cisplatin) ...
read more ↘ vs BEP (bleomycin, etoposide, cisplatin) for intermediate/poor risk germ cell tumors, with discussion of outcomes in patients with a p53 mutation.
↖ read less

Comments 0